Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents

Dermatitis, Contact Clinical Trial

Official title:
Clinical Evaluation of T.R.U.E. TEST® Panel 1.1, 2.1 and 3.1: in Children and Adolescents

Status Completed

Clinical Trial Summary

Open, prospective, single-site, non-randomized study of the efficacy and safety of T.R.U.E. TEST allergens in children and adolescents ages 6-18.

Clinical Trial Description

Three T.R.U.E. TEST panels (1.1, 2.1 and 3.1) containing 28 allergens and a negative control will be applied to the skin on the subject's back and worn for approximately 48 hours. Patch test site skin reactions will be evaluated at days 2, 3 (+1), 7 and 21 following panel application ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00795951
Study type	Interventional
Source	Allerderm
Contact
Status	Completed
Phase	Phase 4
Start date	November 2008
Completion date	November 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00929981` - A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients
Active, not recruiting	`NCT00779792` - Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation	Phase 4
Recruiting	`NCT05492721` - Comparing Tissue Adhesives in Port Site Closure	Phase 3
Active, not recruiting	`NCT02614248` - The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population	N/A
Completed	`NCT00612768` - Clinical Evaluation of T.R.U.E. TEST® Fragrance Mix and Thimerosal Allergens:Bioequivalence of PVP Formulations	Phase 2
Not yet recruiting	`NCT01011621` - Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis	Phase 3